| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 155 | 169 | 172 | 174 | 182 | 187 | 205 | 193 | 206 | 242 | 246 | 259 | 203 | 258 | 238 | 257 | 222 | 294 | 270 | 415 | 365 | 421 | 395 | 390 | 465 | 315 | 458 | 336 | 301 |
| Expenses | 145 | 154 | 156 | 154 | 162 | 161 | 176 | 162 | 172 | 201 | 199 | 219 | 175 | 215 | 204 | 217 | 193 | 224 | 215 | 287 | 266 | 280 | 272 | 278 | 316 | 249 | 311 | 277 | 258 |
| EBITDA | 10 | 15 | 16 | 20 | 19 | 26 | 29 | 32 | 35 | 42 | 47 | 40 | 28 | 43 | 34 | 40 | 29 | 70 | 55 | 128 | 99 | 141 | 123 | 112 | 149 | 67 | 146 | 59 | 42 |
| Operating Profit % | 6 % | 9 % | 9 % | 11 % | 10 % | 13 % | 14 % | 16 % | 16 % | 17 % | 19 % | 10 % | 13 % | 17 % | 14 % | 15 % | 13 % | 24 % | 20 % | 29 % | 27 % | 33 % | 31 % | 28 % | 28 % | 20 % | 22 % | 16 % | 12 % |
| Depreciation | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 9 | 10 | 11 | 12 | 12 | 13 | 12 | 13 | 13 | 13 | 14 | 14 | 15 | 15 | 17 | 16 | 16 | 16 | 17 | 20 |
| Interest | 4 | 4 | 3 | 5 | 4 | 5 | 6 | 7 | 5 | 4 | 4 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 2 | 4 | 4 | 4 | 3 | 1 | 2 | 2 | 5 |
| Profit Before Tax | 1 | 5 | 6 | 8 | 8 | 12 | 16 | 17 | 20 | 29 | 32 | 24 | 12 | 28 | 18 | 24 | 14 | 53 | 39 | 110 | 83 | 122 | 105 | 92 | 130 | 49 | 128 | 39 | 18 |
| Tax | 0 | 1 | 1 | 2 | 2 | 4 | 5 | 27 | 5 | 7 | 5 | 7 | 3 | 7 | 5 | 3 | 4 | 15 | 8 | 26 | 21 | 32 | 23 | 25 | 32 | 17 | 26 | 12 | 4 |
| Net Profit | 1 | 5 | 5 | 7 | 6 | 9 | 11 | -9 | 15 | 21 | 27 | 17 | 9 | 20 | 13 | 22 | 10 | 39 | 31 | 85 | 62 | 89 | 81 | 68 | 98 | 33 | 102 | 28 | 14 |
| EPS in ₹ | 0.44 | 3.55 | 3.66 | 5.17 | 4.45 | 6.77 | 8.66 | -7.25 | 11.82 | 16.71 | 20.84 | 13.48 | 6.81 | 15.88 | 10.08 | 16.97 | 7.77 | 29.97 | 23.81 | 65.90 | 48.23 | 69.56 | 63.44 | 52.66 | 76.28 | 25.60 | 79.18 | 21.67 | 10.83 |
Neuland Laboratories
Neuland Laboratories
15,210.00
-176.00
(-1.14%)
Market Cap
19,740.10 Cr
EPS
202.74
PE Ratio
149.80
Dividend Yield
0.08 %
Industry
Healthcare52 Week High
18,100.00
52 Week Low
10,190.70
PB Ratio
12.95
Debt to Equity
0.09
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
Company News
View All News
Neuland Laboratories Appoints Dr. Ravi Shankar Gopinath as Independent Director6 days ago
Neuland Laboratories Limited announced the appointment of Dr. Ravi Shankar Gopinath as an Independent Director, effective August 1, 2025, for a five-year term. The appointment was approved by shareholders through a postal ballot process conducted via remote e-voting from August 28 to September 26, 2025. The resolution received overwhelming support with 99.997% of votes cast in favor, representing 7,996,901 votes from 472 members, while only 239 votes from 29 members were against the proposal. The total voting participation was 62.33% of outstanding shares, with 79,97,140 votes polled out of 1,28,29,889 total shares held by 45,705 shareholders as of the record date of August 22, 2025.
Neuland Laboratories' Board of Directors approved modifications to executive leadership roles, effective April 1, 2026, subject to shareholder approval. Mr. Sucheth Rao Davuluri will transition from Vice Chairman & CEO to Executive Vice Chairman, focusing on strategic areas including long-term planning, enterprise risk management, stakeholder management, internal audit oversight, and CSR initiatives. Mr. Saharsh Rao Davuluri will move from Vice Chairman & Managing Director to CEO & Managing Director, taking charge of day-to-day operations. The changes are designed to align with the organization's growth plans and balance short-term and long-term objectives. A transition period will run from immediate effect until March 31, 2026, to ensure seamless handover of operational responsibilities. Both executives will continue reporting directly to Executive Chairman Dr. D. R. Rao.
Neuland Laboratories Issues Corrigendum to Postal Ballot Notice for Independent Director AppointmentSep 17, 2025
Neuland Laboratories Limited issued a corrigendum to correct a typographical error in its Postal Ballot Notice dated July 31, 2025. The error was in the proposed Special Resolution regarding Dr. Ravi Shankar Gopinath's appointment as Independent Director, where the end date of his five-year term was incorrectly mentioned as July 31, 2025, instead of July 31, 2030. The corrected resolution shows Dr. Gopinath's term running from August 1, 2025, to July 31, 2030. The e-voting period for the postal ballot runs from August 28, 2025, to September 26, 2025. Dr. Gopinath, aged 59, brings extensive experience from leadership roles at companies including TCS, Geometric Ltd, AVEVA plc, and Schneider Electric. He holds a Ph.D. in Chemical Engineering and currently serves on the boards of Thermax Ltd and Spectris plc. The corrected notice has been sent to shareholders and published in newspapers.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,631.20 | #1 3,92,579.20 | 34.22 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 55.14 | |
5,866.00 | 1,51,582.60 | 65.74 | 9,712.00 | 18.67 | 2,191 | 26.74 | 30.76 | |
1,517.70 | 1,22,213.20 | 22.68 | 28,409.50 | 7.12 | 5,291 | 9.88 | 42.86 | |
3,514.70 | 1,20,726.90 | 59.71 | 11,539.40 | 6.99 | 1,911 | 19.91 | 47.37 | |
1,248.10 | 1,03,884.40 | #1 18.31 | 33,741.20 | 16.73 | 5,725 | 1.26 | 41.85 | |
2,448.00 | 1,00,696.60 | 53.25 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 35.51 | |
988.30 | 99,732.90 | 21.41 | 23,511.00 | 18.55 | 4,615 | 2.60 | 43.75 | |
1,973.60 | 90,496.80 | 24.47 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 51.60 | |
5,442.00 | 65,276.50 | 28.71 | 13,458.30 | 3.70 | 2,216 | 21.39 | 55.81 | |
29,965.00 | 63,514.20 | 43.71 | 6,684.70 | 9.64 | 1,414 | 11.55 | 36.82 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
-4.70 %
Net Income Growth
-13.33 %
Cash Flow Change
21.52 %
ROE
-27.06 %
ROCE
-30.03 %
EBITDA Margin (Avg.)
-24.07 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 512 | 524 | 886 | 1,071 | 1,130 | 1,231 | 1,325 | 1,384 | 1,580 | 1,833 | 2,180 |
| Fixed Assets | 123 | 139 | 466 | 475 | 542 | 653 | 716 | 767 | 758 | 824 | 955 |
| Current Assets | 316 | 314 | 375 | 447 | 454 | 515 | 550 | 581 | 761 | 921 | 1,140 |
| Capital Work in Progress | 42 | 41 | 20 | 126 | 105 | 24 | 17 | 21 | 41 | 46 | 48 |
| Investments | 0 | 0 | 8 | 8 | 8 | 8 | 7 | 4 | 1 | 1 | 109 |
| Other Assets | 347 | 345 | 393 | 463 | 477 | 547 | 585 | 592 | 781 | 962 | 1,068 |
| Total Liabilities | 512 | 524 | 886 | 1,071 | 1,130 | 1,231 | 1,325 | 1,384 | 1,580 | 1,833 | 2,180 |
| Current Liabilities | 295 | 268 | 286 | 367 | 327 | 358 | 369 | 363 | 439 | 428 | 466 |
| Non Current Liabilities | 55 | 69 | 54 | 146 | 104 | 163 | 170 | 180 | 147 | 122 | 189 |
| Total Equity | 162 | 187 | 546 | 558 | 699 | 710 | 787 | 841 | 994 | 1,283 | 1,525 |
| Reserve & Surplus | 152 | 178 | 537 | 549 | 686 | 697 | 774 | 828 | 981 | 1,270 | 1,512 |
| Share Capital | 9 | 9 | 9 | 9 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 1 | -4 | -0 | 5 | 3 | -9 | 3 | 40 | 42 | 44 |
| Investing Activities | -14 | -20 | -42 | -116 | -77 | -49 | -85 | -95 | -61 | -150 | -298 |
| Operating Activities | 13 | 45 | 39 | 11 | 70 | 57 | 189 | 60 | 237 | 261 | 317 |
| Financing Activities | 1 | -24 | -0 | 105 | 12 | -6 | -114 | 38 | -136 | -69 | 25 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 36.22 % | 36.22 % | 36.22 % | 36.22 % | 36.22 % | 36.22 % | 36.22 % | 36.14 % | 36.14 % | 36.03 % | 35.97 % | 32.80 % | 32.74 % | 32.72 % | 32.64 % | 32.68 % | 32.68 % | 32.68 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 21.57 % | 22.69 % | 24.44 % | 25.72 % | 26.46 % | 23.86 % | 22.11 % | 21.69 % |
| DIIs | 0.87 % | 0.04 % | 0.80 % | 0.80 % | 0.80 % | 0.80 % | 6.58 % | 6.55 % | 7.10 % | 6.76 % | 6.99 % | 6.03 % | 6.54 % | 6.39 % | 6.38 % | 9.08 % | 10.97 % | 11.57 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.44 % | 0.46 % | 0.40 % | 0.40 % | 0.40 % | 0.40 % | 0.40 % | 0.40 % | 0.40 % | 0.40 % | 0.40 % | 0.40 % |
| Public / Retail | 34.06 % | 36.62 % | 33.19 % | 32.84 % | 32.43 % | 33.25 % | 31.03 % | 30.09 % | 29.86 % | 29.01 % | 27.86 % | 29.51 % | 27.97 % | 27.05 % | 26.50 % | 26.05 % | 25.86 % | 25.55 % |
| Others | 28.85 % | 27.12 % | 29.80 % | 30.15 % | 30.56 % | 29.74 % | 25.73 % | 26.76 % | 26.51 % | 27.80 % | 7.21 % | 8.57 % | 7.91 % | 7.71 % | 7.61 % | 7.93 % | 7.99 % | 8.12 % |
| No of Share Holders | 0 | 22,412 | 34,978 | 34,332 | 32,426 | 32,257 | 31,976 | 30,600 | 26,948 | 25,223 | 26,824 | 27,723 | 28,616 | 29,077 | 34,567 | 39,315 | 39,333 | 42,419 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 2 | 5 | 5 | 10 | 14 | 12 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.1 | 0.49 | 0.28 | 0.16 | 0.12 | 0.08 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Jul 2021 |  Dividend | ₹ 3.00 /share | 29 Jun 2021 | 2,692.70 | 2,142.20 |
| 15 Jul 2022 | Dividend | ₹ 5.00 /share | 14 Jul 2022 | 1,334.25 | 1,298.00 |
| 12 Jul 2023 | Dividend | ₹ 10.00 /share | 11 Jul 2023 | 2,115.25 | 2,998.80 |
| 13 Jul 2024 | Dividend | ₹ 14.00 /share | 12 Jul 2024 | 7,146.85 | 8,094.80 |
| 31 Jul 2024 |  Annual General Meeting | NA | 31 Jul 2024 | 7,146.85 | 9,051.20 |
| 06 Nov 2024 |  Quarterly Result Announcement | NA | 06 Nov 2024 | 16,250.70 | 15,858.20 |
| 10 Feb 2025 | Quarterly Result Announcement | NA | 10 Feb 2025 | 13,869.35 | 14,247.35 |
| 15 May 2025 | Quarterly Result Announcement | NA | 15 May 2025 | 12,820.80 | 12,472.30 |
| 18 Jul 2025 | Dividend | ₹ 12.00 /share | 18 Jul 2025 | 12,472.30 | 14,496.35 |
| 30 Jul 2025 | Annual General Meeting | NA | 30 Jul 2025 | 12,472.30 | 13,849.10 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 12,306.00 | 13,914.00 |
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
6 days ago
6 days agoShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot6 days ago
6 days agoClosure of Trading Window8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Change in Management10 days ago
10 days agoChange In Designation10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationSep 18, 2025
Sep 18, 2025Corrigendum To The Postal Ballot Notice Dated July 31 2025Sep 17, 2025
Sep 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 11, 2025
Sep 11, 2025Re-Lodgement Of Transfer Request Of Physical SharesSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2025
Sep 02, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 30, 2025
Aug 30, 2025Intimation Under Regulation 30 Of SEBI Listing RegulationsAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 27, 2025
Aug 27, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 26, 2025
Aug 26, 2025Re-Lodgement Of Transfer Requests Of Physical SharesAug 23, 2025
Aug 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Aug 12, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2025
Jul 31, 2025Update On Outcome Of Board Meeting And Change In Directorate Disclosures Regarding Appointment Of Additional DirectorJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2025
Jul 31, 2025Unaudited Financial Results For Quarter Ended June 30 2025Jul 31, 2025
Jul 31, 2025Board Meeting Outcome for Unaudited Financial Results For Quarter Ended June 30 2025Jul 31, 2025
Jul 31, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 30, 2025
Jul 30, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 26, 2025
Jul 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 25, 2025
Jul 25, 2025Addendum To The Notice Of 41St Annual General MeetingJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 15, 2025
Jul 15, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationsJul 15, 2025
Jul 15, 2025Clarification sought from Neuland Laboratories LtdJul 15, 2025
Jul 15, 2025Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30 2025Jul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 05, 2025
Jul 05, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 04, 2025
Jul 04, 2025Notice Of 41St Annual General MeetingJul 04, 2025
Jul 04, 2025Reg. 34 (1) Annual Report.Jul 04, 2025
Jul 04, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationsJun 28, 2025
Jun 28, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Credit RatingJun 21, 2025
Jun 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Jun 19, 2025Disclosure Under Regulation 30 Of SEBI Listing RegulationsJun 17, 2025
Jun 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 17, 2025
Jun 17, 2025Technical Indicators
RSI(14)
Neutral 57.63
ATR(14)
Volatile 586.46
STOCH(9,6)
Neutral 26.43
STOCH RSI(14)
Neutral 28.94
MACD(12,26)
Bearish -131.54
ADX(14)
Strong Trend 27.66
UO(9)
Bearish 52.51
ROC(12)
Downtrend And Accelerating -1.82
WillR(14)
Neutral -40.85
Mutual Fund Holdings
Motilal Oswal Business Cycle Fund Direct-Growth 
HSBC Small Cap Fund Direct-Growth 
ICICI Prudential Flexicap Fund Direct - Growth 
Mahindra Manulife Small Cap Fund Direct - Growth 
Bajaj Finserv Flexi Cap Fund Direct-Growth 
Bajaj Finserv Small Cap Fund Direct-Growth 
WhiteOak Capital Flexi Cap Fund Direct - Growth 
Mirae Asset Small Cap Fund Direct-Growth 
Bandhan Small Cap Fund Direct-Growth 
LIC MF Dividend Yield Fund Direct - Growth 
ITI Small Cap Fund Direct-Growth 
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth 
JM ELSS Tax Saver Fund Direct Plan-Growth 
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
